de Bruin T W
Department of Medicine, University of Massachusetts Medical Center, Worcester 01605.
J Endocrinol Invest. 1988 Jun;11(6):403-8. doi: 10.1007/BF03349068.
TSH receptor antibodies have been detected in the sera of patients with Graves' disease (GD) and Hashimoto's thyroiditis (HT). Since non-human thyroid tissue fractions or cells are used in the majority of assays, the species specificity of TSH receptor antibodies in GD or HT could be important. The species specificity was evaluated by means of an immunoprecipitation assay (IPA) using Triton X-100 solubilized TSH receptors prepared from human, porcine and rat thyroid as well as guinea pig fat cells (GPFC). In each assay the majority (4 or 5) of the 6 patients with GD were IPA-positive. In contrast, 9 out of 11 patients (82%) with HT had a positive human and rat IPA, while only 3 out of 11 (27% p less than 0.05) sera were positive in the porcine and GPFC assays.
no species specificity of TSH receptor antibodies was detected for patients with GD; a selective species specificity for human and rat TSH receptors was found for HT sera. This suggests that TSH receptor antibodies in HT either recognize different determinants on the receptor than the antibodies in GD or are of lower affinity. Furthermore, the use of porcine thyroid tissue or GPFC may lead to an underestimation of the presence and level of TSH receptor antibodies in patients with HT.
在格雷夫斯病(GD)和桥本甲状腺炎(HT)患者的血清中已检测到促甲状腺激素(TSH)受体抗体。由于大多数检测使用的是非人甲状腺组织部分或细胞,GD或HT中TSH受体抗体的物种特异性可能很重要。通过免疫沉淀测定(IPA)评估物种特异性,该测定使用从人、猪和大鼠甲状腺以及豚鼠脂肪细胞(GPFC)制备的经 Triton X - 100 溶解的 TSH 受体。在每次测定中,6 例 GD 患者中的大多数(4 或 5 例)IPA 呈阳性。相比之下,11 例 HT 患者中有 9 例(82%)人源和大鼠源 IPA 呈阳性,而在猪源和 GPFC 测定中,11 份血清中只有 3 份(27%,p < 0.05)呈阳性。
未检测到 GD 患者的 TSH 受体抗体具有物种特异性;发现 HT 血清对人源和大鼠源 TSH 受体具有选择性物种特异性。这表明 HT 中的 TSH 受体抗体要么识别受体上与 GD 中的抗体不同的决定簇,要么亲和力较低。此外,使用猪甲状腺组织或 GPFC 可能导致对 HT 患者中 TSH 受体抗体的存在和水平估计不足。